Assignee
MODERNA TX INC
US·1 granted patent·19 pending applications·18 citations·filing 2014–2025
Top patents by PatentIndex Score
20 records- 0195US10925935B2Terminally Modified RNAMODERNA TX INC·Filed 2018·Granted Feb 23, 2021·18 cites·37 claims
- 0291US2025018062A1Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNA TX INC·Filed 2024·Application pending·0 cites
- 0376US2023416324A1Alternative nucleic acid molecules containing reduced uracil content and uses thereofMODERNA TX INC·Filed 2022·Application pending·0 cites
- 0472US2024238210A1Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosisMODERNA TX INC·Filed 2023·Application pending·0 cites
- 0560US2020254086A1Efficacious mrna vaccinesMODERNA TX INC·Filed 2018·Application pending·0 cites
- 0660US2024425902A1Methods of purifying dna for gene synthesisMODERNA TX INC·Filed 2022·Application pending·0 cites
- 0759US2025362278A1Mass spectrometry of mrnaMODERNA TX INC·Filed 2022·Application pending·0 cites
- 0859US2025262320A1Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndromeMODERNA TX INC·Filed 2025·Application pending·0 cites
- 0957US2024383940A1Synthesis of trinucleotide and tetranucleotide caps for mrna productionMODERNA TX INC·Filed 2022·Application pending·0 cites
- 1056US2024299531A1Therapeutic use of sars-cov-2 mrna domain vaccinesMODERNA TX INC·Filed 2022·Application pending·0 cites
- 1154US2018036369A1Compositions and methods of altering cholesterol levelsMODERNA TX INC·Filed 2017·Application pending·0 cites
- 1253US2017173128A1Targeted adaptive vaccinesMODERNA TX INC·Filed 2014·Application pending·0 cites
- 1352US2018303929A1Herpes simplex virus vaccineMODERNA TX INC·Filed 2016·Application pending·0 cites
- 1451US2024401006A1Mrnas encoding chimeric metabolic reprogramming polypeptides and uses thereofMODERNA TX INC·Filed 2022·Application pending·0 cites
- 1551US2020032274A1Polynucleotide secondary structureMODERNA TX INC·Filed 2018·Application pending·0 cites
- 1646US2024100145A1Vlp enteroviral vaccinesMODERNA TX INC·Filed 2022·Application pending·0 cites
- 1745US2022296517A1Compositions and methods for enhanced delivery of agentsMODERNA TX INC·Filed 2020·Application pending·0 cites
- 1841US2024158458A1Mrnas encoding immune modulating polypeptides and uses thereofMODERNA TX INC·Filed 2020·Application pending·0 cites
- 1940US2022349006A1Cap guides and methods of use thereof for rna mappingMODERNA TX INC·Filed 2020·Application pending·0 cites
- 2036US2018311336A1Broad spectrum influenza virus vaccineMODERNA TX INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MODERNA TX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →